English
简体中文
Total: £ 56.28
2026-03-06 | Pages: 109 | Tables: 113
The global Pharmaceutical Grade Phycocyanin market was valued at US$ 41.02 million in 2025 and is anticipated to reach US$ 58.47 million by 2032, at a CAGR of 5.3% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into th...
2026-03-06 | Pages: 135 | Tables: 132
The global Calcium Supplement market was valued at US$ 4219 million in 2025 and is anticipated to reach US$ 7895 million by 2032, at a CAGR of 9.5% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economi...
2026-03-06 | Pages: 110 | Tables: 109
The global DNA Vaccines market was valued at US$ 5751 million in 2025 and is anticipated to reach US$ 9597 million by 2032, at a CAGR of 7.7% from 2026 to 2032.DNA vaccines are vaccines that use recombinant DNA technology, introducing plasmids or oth...
2026-03-06 | Pages: 108 | Tables: 111
The global Deslanoside market was valued at US$ 1.18 million in 2025 and is anticipated to reach US$ 1.75 million by 2032, at a CAGR of 5.9% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lands...
2026-03-06 | Pages: 130 | Tables: 136
The global Albumin market was valued at US$ 7270 million in 2025 and is anticipated to reach US$ 11200 million by 2032, at a CAGR of 6.5% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscap...
2026-03-06 | Pages: 106 | Tables: 90
The global Elapegademase-lvlr market was valued at US$ 16.62 million in 2025 and is anticipated to reach US$ 21.21 million by 2032, at a CAGR of 3.6% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econo...
2026-03-06 | Pages: 119 | Tables: 120
The global Onychomycosis (Tinea Unguium) Drug market was valued at US$ 3869 million in 2025 and is anticipated to reach US$ 5710 million by 2032, at a CAGR of 5.8% from 2026 to 2032.Onychomycosis is a fungal infection of the toenails or fingernails t...
2026-03-06 | Pages: 93 | Tables: 100
The global Nerve Repair and Re-generation market was valued at US$ 830 million in 2025 and is anticipated to reach US$ 4097 million by 2032, at a CAGR of 26.0% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the gl...
2026-03-06 | Pages: 118 | Tables: 119
The global Interferon market was valued at US$ 3508 million in 2025 and is anticipated to reach US$ 2111 million by 2032, at a CAGR of -7.1% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lands...
2026-03-06 | Pages: 96 | Tables: 92
The global Insulin Lispro market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This ...
2026-03-06 | Pages: 114 | Tables: 110
The global HPMC Capsules market was valued at US$ 758 million in 2025 and is anticipated to reach US$ 1217 million by 2032, at a CAGR of 7.1% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic land...
2026-03-06 | Pages: 93 | Tables: 103
The global Gaucher Disease market was valued at US$ 1537 million in 2025 and is anticipated to reach US$ 2734 million by 2032, at a CAGR of 8.7% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic l...
2026-03-06 | Pages: 112 | Tables: 116
The global Liver Fibrosis Drug market was valued at US$ 11360 million in 2025 and is anticipated to reach US$ 10100 million by 2032, at a CAGR of -1.7% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global eco...
2026-03-06 | Pages: 124 | Tables: 125
The global Crude Heparin market was valued at US$ 3809 million in 2025 and is anticipated to reach US$ 5387 million by 2032, at a CAGR of 5.1% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lan...
2026-03-06 | Pages: 136 | Tables: 132
The global Diagnostic Reagent market was valued at US$ 72260 million in 2025 and is anticipated to reach US$ 95990 million by 2032, at a CAGR of 4.2% from 2026 to 2032.Diagnostic Reagent is any reagent that is used in vitro or in vivo for detection o...
